Strength
10; 10 mg/1; mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462032190
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
EZETIMIBE; SIMVASTATINApproval Type
Generic (ANDA)
FDA Application
ANDA208699On Market Since
6/27/2019
Pharmacological Classes
Decreased Cholesterol Absorption
Dietary Cholesterol Absorption Inhibitor
HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Related Drugs
Same classification
ATORVASTATIN 10 MG TABLET
Generic
16729004415•Accord Healthcare Inc.
$0.0234
per EA
ATORVASTATIN 10 MG TABLET
Generic
16729004417•Accord Healthcare Inc.
$0.0234
per EA
ATORVASTATIN 10 MG TABLET
Generic
00093505610•Teva Pharmaceuticals USA Inc.
$0.0248
per EA
ATORVASTATIN 10 MG TABLET
Generic
00093505698•Teva Pharmaceuticals USA Inc.
$0.0248
per EA
ATORVASTATIN 10 MG TABLET
Generic
00378395005•Mylan Pharmaceuticals Inc.
$0.0248
per EA
ATORVASTATIN 10 MG TABLET
Generic
00378395077•Mylan Pharmaceuticals Inc.
$0.0248
per EA
ATORVASTATIN 10 MG TABLET
Generic
00904629006•Major Pharmaceuticals
$0.0248
per EA
ATORVASTATIN 10 MG TABLET
Generic
00904629061•Major Pharmaceuticals
$0.0248
per EA
ATORVASTATIN 10 MG TABLET
Generic
16571013609•Rising Pharma Holdings Inc.
$0.0248
per EA
ATORVASTATIN 10 MG TABLET
Generic
16571013610•Rising Pharma Holdings Inc.
$0.0248
per EA